48,830
edits
Difference between revisions of "Tyrosine kinase inhibitors"
Jump to navigation
Jump to search
Tyrosine kinase inhibitors (view source)
Revision as of 17:08, 3 October 2014
, 17:08, 3 October 2014no edit summary
| Line 5: | Line 5: | ||
* Gefitinib (Iressa). | * Gefitinib (Iressa). | ||
* Erlotinib (Tarceva). | * Erlotinib (Tarceva). | ||
Others - used in [[RCC]]:<ref>URL: [http://dtb.bmj.com/content/49/11/129.abstract http://dtb.bmj.com/content/49/11/129.abstract]. Accessed on: 3 October 2014</ref> | |||
* Sunitinib (Sutent). | |||
* Sorafenib (Nexavar). | |||
* Pazopanib (Votrient). | |||
==Use== | ==Use== | ||